GDRX earnings

Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2026. First Quarter 2026 Highlights Revenue of $194.0 million Net income of $1.2 million; Net income margin of 0.6% Adjusted Net Income1 of $23.0 million; Adjusted Net Income Margin1 of 11.9% Adjusted EBITDA1 of $58.3 million; Adjusted EBITDA Margin1 of 30.0% Net cash provided by operating activities of $11.8 million "We deliver

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial results after U.S. markets close on Wednesday, May 6, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 7, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, February 25, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, February 26, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live

Company Maintains Full Year 2025 Revenue and Adjusted EBITDA Expectations; Raises Pharma Manufacturer Solutions Revenue Outlook to Approximately 35% Year-Over-Year Growth for 2025 GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025. Third Quarter 2025 Highlights Revenue of $196.0 million Net income of $1.1 million; Net income margin of 0.6% Adjusted Net Income1 of $28.8 million; Adjusted Net Income Margin1 of 14.7% Adjusted EBITDA1 of $66.3 million; Adjusted EBITDA Margin1 of 33.8% Net cash provided by operating activities of

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close on Tuesday, November 4, 2025. GoodRx management will also hold a conference call and webcast the following morning, Wednesday, November 5, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To participate via telephone, please call (800) 715-9871 at least 10 minutes before the conference call is scheduled to begin. The conference ID is 9085550. The call will also be webcast live on the Company's investor relat

Second Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of 34.2% Net cash provided by operating activities of $49.6 million

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets close on Wednesday, August 6, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 7, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's inve

First Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025. First Quarter 2025 Highlights Revenue of $203.0 million Net income of $11.1 million; Net income margin of 5.4% Adjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9% Adjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34.4% Net cash provided by operating activities of $9.4 milli

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor rel

Fourth Quarter and Full Year 2024 Results Substantially In-line with Previous Guidance GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue1 of $198.6 million Net income of $6.7 million; Net income margin of 3.4% Adjusted Net Income1 of $34.7 million; Adjusted Net Income Margin1 of 17.5% Adjusted EBITDA1 of $67.1 million; Adjusted EBITDA Margin1 of 33.8% Net cash provided by operating activities of $44.7 million Exited the quarter with over 7 million consumers of pr

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations websit

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income1 of $31.9 million; Adjusted Net Income Margin1 of 16.4% Adjusted EBITDA1 of $65.0 million; Adjusted EBITDA Margin1 of 33.3% Net cash provided by operating activities of $86.9 million Exited the quarter with over 7 million consumers of prescription-related offerings2 "In a world where there is increasing attention on medicin

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://inve

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released its financial results for the second quarter of 2024. Second Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $200.6 million Net income of $6.7 million; Net income margin of 3.3% Adjusted Net Income1 of $32.4 million; Adjusted Net Income Margin1 of 16.1% Adjusted EBITDA1 of $65.4 million; Adjusted EBITDA Margin1 of 32.6% Net cash provided by operating activities of $9.7 million Exited the quarter with over 7 million consumers of prescription-related offerings2 "We're proud of the progress we're making against

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://inve

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading destination for prescription savings in the U.S., has released its financial results for the first quarter of 2024. First Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $197.9 million Net loss of $1.0 million; Net loss margin of 0.5% Adjusted Net Income1 of $32.6 million; Adjusted Net Income Margin1 of 16.5% Adjusted EBITDA1 of $62.8 million; Adjusted EBITDA Margin1 of 31.7% Net cash provided by operating activities of $42.6 million Exited the quarter with approximately 8 million consumers of prescription-related offerings2 "I'm encouraged by the strides we've m

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time). The event will feature presentations by GoodRx's Interim CEO, Scott Wagner; CFO, Karsten Voermann; as well as other leaders from across the Company and will include an overview of the company's business drivers and its strategy for long-term growth, followed by a Q&A session. A link to access the live webcast, as well as any related materials, will be available on GoodRx's investor relations website at ht

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://i

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024. Fourth Quarter 2023 Highlights Revenue1 and Adjusted Revenue1,2 of $196.6 million Net loss of $25.9 million; Net loss margin of 13.2% Adjusted Net Income2 of $31.1 million; Adjusted Net Income Margin2 of 15.8% Adjusted EBITDA2 of $57.3 million; Adjusted EBITDA Margin2 of 29.1% Net cash provided by operating activities of $15.9 million Exited the quarter with over 7 million consumers of pres

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Thursday, February 29, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 financial results before U.S. markets open on Thursday, November 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https:/

Second quarter financial results exceed previously announced guidance GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, has released its financial results for the second quarter 2023. Second Quarter 2023 Highlights Total revenue of $189.7 million, exceeding previously announced guidance Net income of $58.8 million1; Net income margin of 31.0% Adjusted Net Income2 of $28.4 million; Adjusted Net Income Margin2 of 15.0% Adjusted EBITDA2 of $53.5 million; Adjusted EBITDA Margin2 of 28.2%, exceeding previously announced guidance Net cash provided by operating activities of $29.9 million Over 500,000 p

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, today announced it will release its second quarter 2023 financial results before U.S. markets open on Wednesday, August 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https:/

First quarter financial results exceed previously announced guidance GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), a leading digital healthcare platform, has released its financial results for the first quarter 2023. First Quarter 2023 Highlights Total revenue of $184.0 million, exceeding previously announced guidance Net loss of $3.3 million1; Net loss margin of 1.8% Adjusted Net Income2 of $29.5 million; Adjusted Net Income Margin2 of 16.0% Adjusted EBITDA2 of $53.2 million; Adjusted EBITDA Margin2 of 28.9%, exceeding previously announced guidance Net cash provided by operating activities of $32.3 million Over 450,000 prescribers3 engaged with us t

GoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), a leading digital healthcare platform, today announced it will release its first quarter 2023 financial results before U.S. markets open on Wednesday, May 10, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://investors.goodrx.com,

Fourth quarter financial results exceed previously announced guidance GoodRx Holdings, Inc. (NASDAQ:GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022. Fourth Quarter 2022 Highlights Total revenue of $184.1 million, exceeding previously announced guidance Net loss of $2.01 million; Net loss margin of 1.1% Adjusted Net Income2 of $27.4 million; Adjusted Net Income Margin2 of 14.9% Adjusted EBITDA2 of $49.6 million; Adjusted EBITDA Margin2 of 26.9%, exceeding previously announced guidance Net cash provided by operating activities of $31.9 million Approximately 900,000 prescribers active on GoodRx in the last

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://investors.goodrx.com, where accompanyi

Third quarter financial results exceed previously announced guidance GoodRx Holdings, Inc. (NASDAQ:GDRX), a leading consumer-focused digital platform, has released its financial results for the third quarter of 2022. Third Quarter 2022 Highlights Total revenue of $187.3 million, exceeding previously announced guidance Net loss of $41.71 million; Net loss margin of 22.3% Adjusted Net Income2 of $29.9 million; Adjusted Net Income Margin2 of 16.0% Adjusted EBITDA2 of $52.0 million; Adjusted EBITDA Margin2 of 27.8%, exceeding previously announced guidance Net cash provided by operating activities of $33.7 million Over 865,000 prescribers active on GoodRx in the last 16 months3 E

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its third quarter 2022 financial results after U.S. markets close on Tuesday, November 8, 2022. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company's investor relations website at https://investors.goodrx.com, where accompany

GoodRx Holdings, Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, has released its second quarter 2022 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. A live webcast of the event will be available on the investor relations website at https://investors.goodrx.com. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a uniq

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its second quarter 2022 financial results after U.S. markets close on Monday, August 8, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company's second quarter 2022 financial results on its investor relations website at https://investors.goodrx.com. A live webcast of the event will be available on the investor relations website at ht

GoodRx Holdings, Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, has released its first quarter 2022 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. First Quarter 2022 Results Conference Call Date: Monday, May 9, 2022 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Webcast: https://investors.goodrx.com (live and replay) Dial-in number: (833) 614-1447 Appr

GoodRx (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare's financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx's offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition will enable GoodRx to help more patients receive their prescriptions in an efficient, affordable, and transparent manner, and stay on their prescribed therapies as long as appropriate. In addit

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its first quarter 2022 financial results after U.S. markets close on Monday, May 9, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company's first quarter 2022 financial results on its investor relations website at https://investors.goodrx.com. First Quarter 2022 Results Conference Call Date: Monday, May 9, 2022 Time:

GoodRx expands offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs GoodRx (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced it has entered into a definitive agreement to acquire vitaCare Prescription Services from TherapeuticsMD. VitaCare is a technology and services platform that helps patients navigate key access and adherence barriers for brand medications. Specifically, vitaCare helps patients understand coverage and identify available savings opportunities, and facilitates communications between providers and payors. The platform also offers a seamless path for filling a prescript

GoodRx Holdings, Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, has released its fourth quarter and full year 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 2:00 pm. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Fourth Quarter and Full Year 2021 Results Conference Call Date: Monday, February 28, 2022   Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time   Webcast: https://investors.goodrx.com

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its fourth quarter and full year 2021 financial results after U.S. markets close on Monday, February 28, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company's fourth quarter and full year 2021 financial results on its investor relations website at https://investors.goodrx.com. Fourth Quarter and Full Year 2021 Results Conference C

GoodRx Holdings, Inc. (NASDAQ:GDRX), America's digital resource for healthcare, has released its third quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 2:00 pm. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Third Quarter 2021 Results Conference Call Date: Wednesday, November 10, 2021 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Webcast: https://investors.goodrx.com (live and replay) Dial-in number: (833) 614-1447 Approximately

GoodRx Holdings Inc. (NASDAQ:GDRX), America's digital resource for healthcare, today announced it will release its third quarter 2021 financial results after U.S. markets close on Wednesday, November 10, 2021. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company's business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company's third quarter 2021 financial results on its investor relations website at https://investors.goodrx.com. Third Quarter 2021 Results Conference Call Date: Wednesday, November 10, 2021 Time:

SANTA MONICA, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- GoodRx Holdings, Inc. (NASDAQ:GDRX), America's leading resource for healthcare savings, has released its second quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. Today's conference call and webcast will be extended to feature a presentation on pharma manufacturer solutions. Second Quarter 2021 Results Conference Call  Date:Thursday, August 12, 2021